“…Nanoparticles (NPs) such as liposomes, polymeric NPs, inorganic NPs, etc., are being used as drug carriers for decades [ 80 , 81 , 82 , 83 , 84 , 85 ]. Drug loading in NPs enhances circulation life of hydrophobic drugs in blood, protect nucleic-acid-based therapeutics from serum nucleases, or reduce the adverse off-target effects of drugs [ 86 , 87 , 88 , 89 , 90 ]. Surface of NPs can be engineered with PEG to achieve longer circulation life or with cell-penetrating peptide to enhance cellular uptake [ 91 ], or with targeting ligand to selectively deliver the payloads at targeted tissue [ 92 ].…”